Learn about mediastinal adenopathy, including diagnosis, ICD-10 codes (R59.1, R59.8), clinical documentation requirements, differential diagnosis, and treatment options. This comprehensive guide covers mediastinal lymph node enlargement, causes, symptoms, imaging (CT scan, X-ray), biopsy procedures, and healthcare implications. Find information on mediastinoscopy, staging, and prognosis for patients with enlarged mediastinal lymph nodes.
Also known as
Enlarged lymph nodes
Includes localized and generalized enlargement of lymph nodes.
Other abdominal pain
May indicate mediastinal adenopathy if pain is referred.
Abnormalities of gait and mobility
May be present in advanced disease causing pressure on nerves.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the mediastinal adenopathy due to a specific disease?
When to use each related code
| Description |
|---|
| Mediastinal Adenopathy |
| Sarcoidosis |
| Lymphoma |
Coding mediastinal adenopathy without specifying laterality (right, left, or bilateral) can lead to claim denials and inaccurate reporting.
Lack of documentation clarifying clinical significance (e.g., isolated finding, infection, malignancy) can hinder accurate code assignment and reimbursement.
Failing to document the underlying etiology of mediastinal adenopathy can lead to coding errors and affect quality reporting and data analysis.
Patient presents with concerns regarding mediastinal adenopathy. Symptoms include persistent cough, unexplained weight loss, and intermittent chest discomfort, although the patient denies fever, chills, or night sweats. Physical examination revealed normal breath sounds and no palpable lymphadenopathy in the cervical or supraclavicular regions. Imaging studies, including a chest X-ray and subsequent contrast-enhanced CT scan of the chest, demonstrate enlarged mediastinal lymph nodes, measuring greater than 1 cm in short axis diameter. Differential diagnosis includes lymphoma, sarcoidosis, granulomatous disease, metastatic carcinoma, and infectious etiologies such as tuberculosis or histoplasmosis. Laboratory workup includes a complete blood count with differential, comprehensive metabolic panel, lactate dehydrogenase, and purified protein derivative skin test or interferon-gamma release assay for tuberculosis screening. Further evaluation with mediastinoscopy and biopsy is recommended to obtain tissue for histopathological analysis and establish a definitive diagnosis. Patient education provided regarding the potential causes of mediastinal lymphadenopathy, the importance of diagnostic testing, and the potential need for further intervention depending on biopsy results. Follow-up appointment scheduled to discuss biopsy findings and formulate a treatment plan based on the final diagnosis. Medical coding will be determined upon completion of diagnostic workup and establishment of a definitive diagnosis, considering ICD-10 codes for lymphadenopathy, mediastinal disease, and other potential underlying etiologies. Appropriate CPT codes for the diagnostic procedures performed, including imaging studies and mediastinoscopy, will be used for billing purposes. This documentation supports the medical necessity of the diagnostic procedures performed and guides subsequent management decisions.